Literature DB >> 10189457

Assessment of a bolus-tracking technique in helical renal CT to optimize nephrographic phase imaging.

B A Birnbaum1, J E Jacobs, C P Langlotz, P Ramchandani.   

Abstract

PURPOSE: To evaluate a bolus-tracking technique in helical computed tomography (CT) for identifying the onset of the nephrographic phase and to determine the effect of varying the volume and injection rate of contrast material on nephrographic phase onset.
MATERIALS AND METHODS: Seventy-five patients underwent bolus tracking of contrast material followed by helical renal CT. In 50 patients, 150 mL of 60% iodinated contrast material (iohexol or iothalamate meglumine) was injected at either 2 mL/sec (25 patients [group 1]) or 3 mL/sec (25 patients [group 2]). In 25 patients who had previously undergone nephrectomy, 100 mL of 60% iodinated contrast material was injected at 3 mL/sec (group 3). Nephrographic phase onset was determined by visually assessing the transition to a homogeneous nephrogram during a monitoring scan series starting 40 seconds after injection.
RESULTS: Nephrographic phase onset ranged from 60 to 136 seconds (mean, 89 seconds +/- 17 [+/- SD]). Statistically significant differences in mean onset times were observed among groups 1 (103 seconds +/- 12), 2 (91 seconds +/- 16), and 3 (75 seconds +/- 9) (P < .001). Multiple regression analysis showed patient age, contrast material volume, and injection rate to be independent predictors of nephrographic phase onset. Contrast material volume, patient age, and patient weight were independent predictors of the degree of renal enhancement.
CONCLUSION: Nephrographic phase onset is highly dependent on methods of contrast material administration and patient characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10189457     DOI: 10.1148/radiology.211.1.r99ap4187

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions.

Authors:  Ravinder Kaur; Mamta Juneja; A K Mandal
Journal:  Med Biol Eng Comput       Date:  2019-11-21       Impact factor: 2.602

2.  Waiting to exhale: salvaging the nondiagnostic CT pulmonary angiogram by using expiratory imaging to improve contrast dynamics.

Authors:  Yung Hsin Chen; Vinodkumar Velayudhan; David I Weltman; Dvorah Balsam; Nick Patel; Kathryn A Draves; Kathryn A Robinson; Thinh H Vu
Journal:  Emerg Radiol       Date:  2008-01-10

Review 3.  Multidetector CT of the kidney.

Authors:  E M Coppenrath; U G Mueller-Lisse
Journal:  Eur Radiol       Date:  2006-03-28       Impact factor: 7.034

4.  The role of imaging in the management of cardiorenal syndrome.

Authors:  Sajid Melvin George; Kambiz Kalantarinia
Journal:  Int J Nephrol       Date:  2011-01-24

5.  Automated Identification of Optimal Portal Venous Phase Timing with Convolutional Neural Networks.

Authors:  Jingchen Ma; Laurent Dercle; Philip Lichtenstein; Deling Wang; Aiping Chen; Jianguo Zhu; Hubert Piessevaux; Jun Zhao; Lawrence H Schwartz; Lin Lu; Binsheng Zhao
Journal:  Acad Radiol       Date:  2019-05-28       Impact factor: 5.482

6.  Effect of thin overlapping reconstruction on the attenuation of small (< or = 3 cm) renal cysts in the nephrographic phase of MDCT: a phantom study.

Authors:  Sun Ho Kim; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2006 Oct-Dec       Impact factor: 3.500

7.  Optimization of scan delay for multi-phase computed tomography by using bolus tracking in normal canine kidney.

Authors:  Hyun Cho; Da-Hae Lee; Ah-Young Cha; Dong-Eun Kim; Dong-Woo Chang; Jihye Choi
Journal:  J Vet Sci       Date:  2018-03-31       Impact factor: 1.672

8.  Is a single portal venous phase in contrast-enhanced CT sufficient to detect metastases or recurrence in clear cell renal cell carcinoma? - a single-center retrospective study.

Authors:  Florian Hagen; Felix Peisen; Jakob Spogis; Antonia Mair; Konstantin Nikolaou; Arnulf Stenzl; Stephan Kruck; Jens Bedke; Sascha Kaufmann; Wolfgang M Thaiss
Journal:  Cancer Imaging       Date:  2022-01-21       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.